Cryofocus Medtech (Shanghai) Co., Ltd. logo

Cryofocus Medtech (Shanghai) Co., Ltd. (6922)

Market Open
11 Dec, 03:30
HKEX HKEX
5. 95
HKD
-0.25
-4.03%
HKD
1.65B Market Cap
- P/E Ratio
0% Div Yield
14,000 Volume
- Eps
6.2 HKD
Previous Close
Day Range
5.92 6.28
Year Range
3.2 14.02
Want to track 6922 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

6922 trading today lower at 5.95 HKD, a decrease of 4.03% from yesterday's close, completing a monthly decrease of -2.94% or 0.18 HKD. Over the past 12 months, 6922 stock lost -26.99%.
6922 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

6922 Chart

Similar

Chaoju Eye Care Holdings Ltd.
2.66 HKD
+1.53%
MicroTech Medical (Hangzhou) Co., Ltd.
7.29 HKD
+2.82%
Town Health International Medical Group Ltd.
0.25 HKD
0%
Perfect Medical Health Management Ltd.
1.41 HKD
-1.4%
Rici Healthcare Holdings Ltd.
0.95 HKD
-1.04%

Cryofocus Medtech (Shanghai) Co., Ltd. (6922) FAQ

What is the stock price today?

The current price is 5.95 HKD.

On which exchange is it traded?

Cryofocus Medtech (Shanghai) Co., Ltd. is listed on HKEX.

What is its stock symbol?

The ticker symbol is 6922.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 1.65B.

Has Cryofocus Medtech (Shanghai) Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Cryofocus Medtech (Shanghai) Co., Ltd. Profile

Health Care Technology Industry
Healthcare Sector
- CEO
HKEX Exchange
- ISIN
China Country
370 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Cryofocus Medtech (Shanghai) Co., Ltd. is a pioneering medical device company focused on the development, manufacturing, and distribution of minimally invasive interventional cryotherapy products. The company plays a critical role in addressing a variety of cardiovascular and other significant health conditions through its innovative solutions. Established in 2013, Cryofocus Medtech is dedicated to improving patient outcomes and elevating the standard of care in the People's Republic of China. It specializes in creating cutting-edge technology for vascular interventional therapy aimed at treating atrial fibrillation, hypertension, and other cardiovascular diseases, as well as natural orifice transluminal endoscopic surgery for urinary, respiratory, and digestive diseases.

Products and Services

Bladder Cryoablation System: A state-of-the-art cryotherapy device engineered for the treatment of non-muscle-invasive bladder cancer. This innovative system offers a minimally invasive solution, aiming to reduce patient discomfort and recovery time compared to traditional treatment methods. The Bladder Cryoablation System represents a significant advancement in cancer care, providing a targeted approach to tumor treatment while minimizing damage to surrounding healthy tissue.

Endoscopic Clip for Anastomosis: An anastomotic device designed for the precise and secure closure of soft tissue within the digestive tract. This product is vital for procedures requiring the joining of tissue or organs, ensuring a seamless healing process post-surgery. The Endoscopic Clip for Anastomosis plays a crucial role in gastrointestinal surgeries, offering an innovative solution that promotes faster recovery and reduces the risk of complications associated with traditional suturing techniques.

Contact Information

Address: Building 15
Phone: 86 21 2097 7850